SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
03-Apr-24 4:05 PM View: | Astria Therapeutics, Inc. (ATXS) | 01-Apr-24 | Option Exercise | 10,000 | $3.87 | $38,700.00 | 100% 0 to 10.0K | |
03-Apr-24 4:05 PM View: | Astria Therapeutics, Inc. (ATXS) | 01-Apr-24 | Planned Option Sale | 10,000 | $13.59 | $135,939.00 | (100%) 10.0K to 0 | |
30-Jan-24 5:03 PM View: | Astria Therapeutics, Inc. (ATXS) | 29-Jan-24 | Option Exercise | 9,200 | $3.87 | $35,604.00 | 100% 0 to 9.2K | |
30-Jan-24 5:03 PM View: | Astria Therapeutics, Inc. (ATXS) | 29-Jan-24 | Planned Option Sale | 9,200 | $11.15 | $102,552.00 | (100%) 9.2K to 0 | |
30-Jan-24 5:03 PM View: | Astria Therapeutics, Inc. (ATXS) | 26-Jan-24 | Option Exercise | 800 | $3.87 | $3,096.00 | 100% 0 to 0.8K | |
30-Jan-24 5:03 PM View: | Astria Therapeutics, Inc. (ATXS) | 26-Jan-24 | Planned Option Sale | 800 | $11.02 | $8,812.00 | (100%) 0.8K to 0 | |
29-Jun-21 4:16 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 28-Jun-21 | Market Purchase | 1,100 | $9.16 | $10,076.00 | 100% 0 to 1.1K | (3%) |